John K. Keppler - Dec 2, 2022 Form 4 Insider Report for Enviva Inc. (EVA)

Role: Former Chairman and CEO
Signature: /s/ Jason E. Paral, as attorney-in-fact for John K. Keppler
Stock symbol: EVA
Transactions as of: Dec 2, 2022
Transactions value $: -$11,000,000
Form type: 4
Date filed: 12/5/2022, 05:18 AM
Previous filing: Nov 16, 2022
Next filing: Apr 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVA	Common Stock	Sale	-$11M	-200K	-20.54%	$55.00	774K	Dec 2, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

John K. Keppler is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The reporting person's sale of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 4,943 shares, with the reporting person's purchase of 4,943 shares of the issuer's common stock at a price of $50.65 per share on October 12, 2022. The reporting person has agreed to pay to the issuer, upon settlement of the sale, $20,127.76, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
F2	In addition to a forthcoming planned contribution of shares of the issuer's common stock to a charitable remainder trust, in connection with his previously disclosed heart condition, the reporting person sold the securities reported herein principally for estate planning and charitable purposes, which include supporting several personal philanthropic initiatives. The securities sold as reported herein were acquired by a fund managed by Inclusive Capital Partners, L.P., a Delaware limited partnership ("In-Cap"). Jeffrey W. Ubben indirectly controls In-Cap.

Content

The reporting person's sale of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 4,943 shares, with the reporting person's purchase of 4,943 shares of the issuer's common stock at a price of $50.65 per share on October 12, 2022. The reporting person has agreed to pay to the issuer, upon settlement of the sale, $20,127.76, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.

In addition to a forthcoming planned contribution of shares of the issuer's common stock to a charitable remainder trust, in connection with his previously disclosed heart condition, the reporting person sold the securities reported herein principally for estate planning and charitable purposes, which include supporting several personal philanthropic initiatives. The securities sold as reported herein were acquired by a fund managed by Inclusive Capital Partners, L.P., a Delaware limited partnership ("In-Cap"). Jeffrey W. Ubben indirectly controls In-Cap.